Know what’s really happening at
Medra before you sign on.
- On the roadmap
- AI Drug Discovery
- Lab Automation
- Robotics
Medra builds autonomous laboratories where AI-directed robots run biological experiments with the same tools human scientists use, generating the reproducible data drug discovery models lack. A $52M Series A and a closed-loop Genentech partnership have made it one of the most-watched physical AI companies in life science.
How we do it.
Most "AI market intel" is a summarized crawl of press releases. This Altis research is built from our knowledge graph of sector expert calls, synthesized with public sources.
Medra
- Series A led by Human Capital, December 2025
- $52M
- Total funding including pre-seed and seed
- $63M
- Closed-loop biopharma partnership announced with the Series A
- Genentech
- SF industrial building leased at 1301 Folsom Street, Feb 2026
- 38,000-square-foot
- Planned scale of the autonomous flagship lab
- 100 robots
- Michelle Lee left a planned NYU professorship to start Medra
- 2022
Press reported
Altis Verified
What's in the report
Most "AI market intel" is a summarized crawl of press releases. This is what customers, competitors, and former employees actually told us.
Market Overview
Market structure, where the company sits, and growth drivers.
- market map
- AI Drug Discovery landscape
- AI Drug Discovery growth rate
- CAGR
Total Addressable Market
Bottom-up TAM / SAM / SOM.
- Medra TAM
- AI Drug Discovery market size
- market opportunity
Company Overview
What the company does and how it operates.
- what does Medra do
- Medra product
- business model
Product / Go-to-Market
Product, GTM motion, ICP, and who buys.
- Medra customers
- who uses Medra
- Medra ICP
- go-to-market
Competitive Dynamics
The Altis Market Map and the Altis Win-Rate Index.
- Medra competitors
- Medra alternatives
- who competes with Medra
- Medra win rate
Customer Signals
Retention, satisfaction, and win/loss signals.
- Medra reviews
- Medra NRR
- Medra churn
- current customers
- switching costs
Investment Debates
Investment thesis, moat, bull/bear, and key risks.
- Medra investment thesis
- Medra moat
- bull case bear case
- Medra risk factors
Monetization & Financials
Business model, revenue model, and unit economics.
- Medra ARR
- Medra revenue
- Medra valuation
- unit economics
Team and culture
Founders, leadership, and org.
- Medra founders
- Medra CEO background
- leadership team
- headcount
Trusted by
Ready to see the full picture?
Based on public reporting and company announcements as of July 2026.